Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details)

v3.20.4
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net revenue $ 105,122 $ 64,439
Direct operating costs 64,821 41,186
Selling and marketing 6,582 1,522
General and administrative 22,811 17,912
Research and development 9,311 871
Change in contingent consideration (1,000) (344)
Depreciation and amortization 9,905 3,006
Impairment and unoccupied lease charges 963 219
Total operating expenses 113,393 64,372
Operating (loss) income (8,271) 67
Healthcare IT [Member]    
Net revenue 93,324 51,172
Direct operating costs 55,653 30,798
Selling and marketing 6,549 1,487
General and administrative 14,578 11,124
Research and development 9,311 871
Change in contingent consideration (1,000) (344)
Depreciation and amortization 9,587 2,689
Impairment and unoccupied lease charges 963 219
Total operating expenses 95,641 46,844
Operating (loss) income (2,317) 4,328
Practice Management [Member]    
Net revenue 11,798 13,267
Direct operating costs 9,168 10,388
Selling and marketing 33 35
General and administrative 1,978 2,067
Research and development
Change in contingent consideration
Depreciation and amortization 318 317
Impairment and unoccupied lease charges
Total operating expenses 11,497 12,807
Operating (loss) income 301 460
Unallocated Corporate Expenses [Member]    
Net revenue
Direct operating costs
Selling and marketing
General and administrative 6,255 4,721
Research and development
Change in contingent consideration  
Depreciation and amortization
Impairment and unoccupied lease charges
Total operating expenses 6,255 4,721
Operating (loss) income $ (6,255) $ (4,721)